WA
TMO icon

Wealth Alliance’s Thermo Fisher Scientific TMO Stock Holding History

Wealth Alliance’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
2,095
-152
-7% -$82.5K 0.1% 180
2025
Q4 		$1.3M Sell
2,247
-27
-1% -$15.3K 0.13% 146
2025
Q3 		$1.1M Sell
2,274
-567
-20% -$264K 0.11% 163
2025
Q2 		$1.15M Buy
2,841
+821
+41% +$343K 0.13% 152
2025
Q1 		$1.01M Sell
2,020
-239
-11% -$129K 0.12% 161
2024
Q4 		$1.18M Sell
2,259
-487
-18% -$268K 0.14% 144
2024
Q3 		$1.7M Sell
2,746
-14
-0.5% -$8.29K 0.2% 102
2024
Q2 		$1.53M Sell
2,760
-117
-4% -$67K 0.2% 99
2024
Q1 		$1.67M Sell
2,877
-191
-6% -$107K 0.22% 97
2023
Q4 		$1.63M Buy
3,068
+494
+19% +$239K 0.23% 95
2023
Q3 		$1.3M Buy
2,574
+101
+4% +$53.8K 0.21% 104
2023
Q2 		$1.29M Sell
2,473
-1,005
-29% -$542K 0.19% 112
2023
Q1 		$2M Sell
3,478
-249
-7% -$140K 0.32% 54
2022
Q4 		$2.05M Buy
3,727
+739
+25% +$392K 0.36% 52
2022
Q3 		$1.52M Buy
2,988
+108
+4% +$60.4K 0.3% 63
2022
Q2 		$1.56M Buy
2,880
+1,282
+80% +$706K 0.3% 68
2022
Q1 		$944K Sell
1,598
-240
-13% -$138K 0.19% 124
2021
Q4 		$1.23M Sell
1,838
-111
-6% -$69.3K 0.25% 87
2021
Q3 		$1.11M Buy
1,949
+495
+34% +$272K 0.25% 90
2021
Q2 		$733K Buy
1,454
+124
+9% +$58.5K 0.17% 139
2021
Q1 		$607K Buy
1,330
+113
+9% +$53.9K 0.17% 145
2020
Q4 		$567K Buy
1,217
+134
+12% +$62.8K 0.17% 150
2020
Q3 		$478K Buy
1,083
+84
+8% +$34.7K 0.17% 149
2020
Q2 		$362K Buy
999
+188
+23% +$63K 0.14% 184
2020
Q1 		$230K Buy
+811
New +$256K 0.12% 199

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wealth Alliance's TMO Position: Q1 2026 in Review

Wealth Alliance reduced its Thermo Fisher Scientific (TMO) stake by 6.8% in Q1 2026, selling an estimated $82.5K and leaving 2,095 shares worth $1.03M. The position accounts for 0.1% of the portfolio, ranked #180.

Wealth Alliance first reported a position in TMO in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.05M in Q4 2022. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Wealth Alliance held 2,095 shares of Thermo Fisher Scientific worth $1.03M as of Q1 2026.
  • Wealth Alliance sold 152 Thermo Fisher Scientific shares in Q1 2026, an estimated $82.5K.
  • Thermo Fisher Scientific made up 0.1% of Wealth Alliance's portfolio in Q1 2026, its #180 holding.
  • Wealth Alliance first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 25 quarters since.
  • Wealth Alliance's Thermo Fisher Scientific position peaked at $2.05M in Q4 2022.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.